Apellis Pharmaceuticals Inc. (APLS) Rose 5.9% or 1.15 To Price $20.63 On Tuesday


Apellis Pharmaceuticals Inc. (APLS) rose 5.9% or 1.15 to $20.63. It is close to 155261 shares traded, which is 25.43% compare to the average total volume 610436. The market cap of APLS is $1.16 billion. The year to date change is 48.93%. The 52 week price range is from $11.45 to $32.0. Price of APLS have changed 0.46% during last week. It have changed 6.39% over last month, 43.02% over last 3 months, 11.57% over last 6 months and -4.60% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for APLS is 16.16. It is -21.67% below current price. The 200-day Moving Averages for APLS is 16.97. It is -17.74% below current price. The 52-week High is 32.0. It is 55.11% from the current price. The 52-week Low is 11.45. It is -44.50% from current price.

There are some statistics of APLS. It is has market cap $1.16 billion. The share outstanding is 56.29 million. The average volume is 610436. The percent of top 15 Institution holding is 67.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of APLS is -82.28%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of APLS is -66.12%.


Tags:

Share this post